Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Trastornos del movimiento Movement disorders 103 artículos Viendo del 1 al 40 de 103 artículos
Pub MED

[Drug induced movement disorders: role of antipsychotic drugs].NUEVO

Damásio J, Carvalho S.
Acta Med Port. 2011 Dec;24 Suppl 4:915-22. Review. Portuguese.
Pub MED

15th international congress of Parkinson's disease and movement disorders and inaugural melanoma and cutaneous malignancy meeting.NUEVO

Alexander W.
P T. 2011 Sep;36(9):599-603. No abstract available.
Pub MED

Video assessment of finger tapping for Parkinson's disease and other movement disorders.NUEVO

Criss K, McNames J.
Conf Proc IEEE Eng Med Biol Soc. 2011;2011:7123-6. doi: 10.1109/IEMBS.2011.6091800.
Pub MED

Towards remote evaluation of movement disorders via smartphones.NUEVO

Kostikis N, Hristu-Varsakelis D, Arnaoutoglou M, Kotsavasiloglou C, Baloyiannis S.
Conf Proc IEEE Eng Med Biol Soc. 2011;2011:5240-3. doi: 10.1109/IEMBS.2011.6091296.
Pub MED

Sleep-to-wake transition movement disorders.NUEVO

Vetrugno R, Montagna P.
Sleep Med. 2011 Dec;12 Suppl 2:S11-6. doi: 10.1016/j.sleep.2011.10.005. Review.
Pub MED

Surgery for movement disorders.NUEVO

Hu W, Klassen BT, Stead M.
J Neurosurg Sci. 2011 Dec;55(4):305-17. Review.
Pub MED

Movement disorders in 2011: Translating new research findings into clinical practice.NUEVO

Klein C, Krainc D.
Nat Rev Neurol. 2011 Dec 20;8(2):65-6. doi: 10.1038/nrneurol.2011.212. Review. No abstract available.
Pub MED

How best to address these common movement disorders.NUEVO

Yaman A, Akdeniz M, Yaman H.
J Fam Pract. 2011 Dec;60(12):721-5. Review. No abstract available.
Pub MED

Tardive movement disorders: a practical approach.NUEVO

Saifee TA, Edwards MJ.
Pract Neurol. 2011 Dec;11(6):341-8. doi: 10.1136/practneurol-2011-000077. Review. No abstract available.
Pub MED

Moving forward: advances in the treatment of movement disorders with deep brain stimulation.NUEVO

Schiefer TK, Matsumoto JY, Lee KH.
Front Integr Neurosci. 2011 Nov 9;5:69. doi: 10.3389/fnint.2011.00069.
Pub MED

Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.NUEVO

Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ.
J Neuroimmunol. 2011 Dec 15;240-241:121-8. doi: 10.1016/j.jneuroim.2011.10.005.
Pub MED

Drug-induced movement disorders and Syndenham's chorea in an antipsychotic-treated young child.NUEVO

Jadhav S, Coffey BJ.
J Child Adolesc Psychopharmacol. 2011 Oct;21(5):487-90. doi: 10.1089/cap.2011.2157. No abstract available.
Pub MED

Educating child neurologists about movement disorders.NUEVO

Singer HS.
Semin Pediatr Neurol. 2011 Jun;18(2):98-103. doi: 10.1016/j.spen.2011.05.003.
Pub MED

Movement disorders in spinocerebellar ataxias.NUEVO

Pedroso JL, Felicio AC, Braga-Neto P, Barsottini OG.
Mov Disord. 2011 Oct;26(12):2302. doi: 10.1002/mds.23928. No abstract available.
Pub MED

Projected numbers of people with movement disorders in the years 2030 and 2050.NUEVO

Bach JP, Ziegler U, Deuschl G, Dodel R, Doblhammer-Reiter G.
Mov Disord. 2011 Oct;26(12):2286-90. doi: 10.1002/mds.23878.
Pub MED

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.NUEVO

Jankovic J, Clarence-Smith K.
Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149. Review.
Pub MED

Movement disorders on YouTube--caveat spectator.NUEVO

Stamelou M, Edwards MJ, Espay AJ, Fung VS, Hallett M, Lang AE, Tijssen MA, Bhatia KP.
N Engl J Med. 2011 Sep 22;365(12):1160-1. doi: 10.1056/NEJMc1107673. No abstract available.
Pub MED

MicroRNAs in Experimental Models of Movement Disorders.NUEVO

Lee ST, Kim M.
J Mov Disord. 2011 Oct;4(2):55-9. doi: 10.14802/jmd.11011. Review.
Pub MED

Cognitive and psychiatric phenotypes of movement disorders in children: a systematic review.NUEVO

Ben-Pazi H, Jaworowski S, Shalev RS.
Dev Med Child Neurol. 2011 Dec;53(12):1077-84. doi: 10.1111/j.1469-8749.2011.04134.x. Review.
Pub MED

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.NUEVO

Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, Cortelli P, Nobili L, Bruni O, Dauvilliers Y, Lin L, Edwards MJ, Mignot E, Bhatia KP.
Brain. 2011 Dec;134(Pt 12):3477-89. doi: 10.1093/brain/awr244.
Pub MED

Sleep-related movement disorders.NUEVO

Freedom T.
Dis Mon. 2011 Aug;57(8):438-47. doi: 10.1016/j.disamonth.2011.06.006. Review. No abstract available.
Pub MED

Reduced serum caeruloplasmin levels in non-wilsonian movement disorders.NUEVO

Ling H, Bhidayasiri R.
Eur Neurol. 2011;66(3):123-7. doi: 10.1159/000330538.
Pub MED

Movement disorders in focus: experts debate on pathophysiology and concomitant signs.NUEVO

Onofrj M, Thomas A.
Expert Rev Neurother. 2011 Sep;11(9):1239-41. doi: 10.1586/ern.11.120.
Pub MED

Guidelines for the use of botulinum toxin in movement disorders and spasticity.NUEVO

Jabeen A, Kandadai RM, Kannikannan MA, Borgohain R.
Ann Indian Acad Neurol. 2011 Jul;14(Suppl 1):S31-4. doi: 10.4103/0972-2327.83099. No abstract available.
Pub MED

Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis.NUEVO

Bosco DA, LaVoie MJ, Petsko GA, Ringe D.
Cold Spring Harb Perspect Biol. 2011 Oct 1;3(10):a007500. doi: 10.1101/cshperspect.a007500. Review.
Pub MED

Treatment of Apathy in Huntington's Disease and Other Movement Disorders.NUEVO

Krishnamoorthy A, Craufurd D.
Curr Treat Options Neurol. 2011 Oct;13(5):508-19. doi: 10.1007/s11940-011-0140-y.
Pub MED

Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.NUEVO

Merello M, Gerschcovich ER, Ballesteros D, Cerquetti D.
Parkinsonism Relat Disord. 2011 Nov;17(9):705-7. doi: 10.1016/j.parkreldis.2011.07.002.
Pub MED

A prospective series of patients with hyperglycaemia-associated movement disorders.NUEVO

Cervantes-Arriaga A, Arrambide G, Rodríguez-Violante M.
J Clin Neurosci. 2011 Oct;18(10):1329-32. doi: 10.1016/j.jocn.2011.01.029.
Pub MED

Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important?NUEVO

Driver-Dunckley E, Stonnington CM, Locke DE, Noe K.
Psychosomatics. 2011 Jul-Aug;52(4):337-45. doi: 10.1016/j.psym.2011.01.008.
Pub MED

How "psychogenic" are psychogenic movement disorders?NUEVO

Stone J, Edwards MJ.
Mov Disord. 2011 Aug 15;26(10):1787-8. doi: 10.1002/mds.23882. No abstract available.
Pub MED

Neurodevelopmental movement disorders - an update on childhood motor stereotypies.NUEVO

Barry S, Baird G, Lascelles K, Bunton P, Hedderly T.
Dev Med Child Neurol. 2011 Nov;53(11):979-85. doi: 10.1111/j.1469-8749.2011.04058.x. Review.
Pub MED

Pathological basal ganglia activity in movement disorders.NUEVO

Wichmann T, Dostrovsky JO.
Neuroscience. 2011 Dec 15;198:232-44. doi: 10.1016/j.neuroscience.2011.06.048. Review.
Pub MED

PET/CT in diagnosis of movement disorders.NUEVO

Berti V, Pupi A, Mosconi L.
Ann N Y Acad Sci. 2011 Jun;1228:93-108. doi: 10.1111/j.1749-6632.2011.06025.x. Review.
Pub MED

Psychopathology and psychogenic movement disorders.NUEVO

Kranick S, Ekanayake V, Martinez V, Ameli R, Hallett M, Voon V.
Mov Disord. 2011 Aug 15;26(10):1844-50. doi: 10.1002/mds.23830.
Pub MED

Behavioral pharmacology of orofacial movement disorders.NUEVO

Koshikawa N, Fujita S, Adachi K.
Int Rev Neurobiol. 2011;97:1-38. doi: 10.1016/B978-0-12-385198-7.00001-1. Review.
Pub MED

Movement disorders 2011--the state of the journal.NUEVO

Olanow CW, Obeso JA.
Mov Disord. 2011 Jun;26(7):1183-4. doi: 10.1002/mds.23840. No abstract available.
Pub MED

Loss of specificity in Basal Ganglia related movement disorders.NUEVO

Bronfeld M, Bar-Gad I.
Front Syst Neurosci. 2011 Jun 3;5:38. doi: 10.3389/fnsys.2011.00038.
Pub MED

Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders.NUEVO

Ferrara J, Stamey W, Strutt AM, Adam OR, Jankovic J.
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):141-8. doi: 10.1176/appi.neuropsych.23.2.141.
Pub MED

Movement disorders emergencies Part 2: hyperkinetic disorders.NUEVO

Robottom BJ, Factor SA, Weiner WJ.
Arch Neurol. 2011 Jun;68(6):719-24. doi: 10.1001/archneurol.2011.117. Review.
Pub MED

FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes.NUEVO

Seixas AI, Vale J, Jorge P, Marques I, Santos R, Alonso I, Fortuna AM, Pinto-Basto J, Coutinho P, Margolis RL, Sequeiros J, Silveira I.
Behav Brain Funct. 2011 Jun 3;7:19. doi: 10.1186/1744-9081-7-19.
Viendo del 1 al 40 de 103 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.